Regeneron Pharmaceuticals Inc. earnings per share and revenue

RGO earnings per share for the last quarter are 8.85 EUR whereas the estimation was 9.43 EUR which accounts for -6.11% surprise. Företagets omsättning för samma period uppgår till 2.91 B EUR trots den uppskattade siffran 2.99 B EUR. Estimated earnings per share for the next quarter are 9.74 EUR, and revenue is expected to reach 3.10 B EUR. Also watch annual changes over time to get a bigger picture of RGO earnings per share and revenue dynamics.